Access up-to-date information on prescription medications and drugs marketed in Peru. Search by product, laboratory, pathology, interactions, or pharmacological and therapeutic indices.
7.1.4
March 15, 2026
Novedades en el aplicativo: AMOIDIN CL 12 H AXONA F FEMOSTON MINI GINGISONA B MENTA FRESH GINGISONA B SPRAY HEMORRODIL NF IRALTONE KITADOL FORTE LOTRIX MET MATERNA DHA MATERNA G-BALANCE NANCARE COMFORT NANCARE DDHA + VITAMINA D NANCARE GOS FOS NANCARE PROTECT OSTENIL PLUS PROBIOTICL PROBIOTIL V PRONTAL QUIMAGESICO SR SIAGLIDE MET SILDENAFILO UROSEPTIC
MorePR Vademécum Perú 2026 is a mobile application that provides updated information on prescription medications and drugs marketed in Peru. It allows users to search for information through various indices like products, laboratories, pathologies, and drug interactions.
PR Vademécum Perú 2026 was developed by Clyna S.A. and is based on reliable sources such as drug manufacturers and current medical-pharmacological literature.
PR Vademécum Perú 2026 is available for iPhone, iPad, and iPod devices.
The latest version of PR Vademécum Perú 2026 is 7.1.4, which was last updated on March 15, 2026. This indicates a commitment to providing current information.
PR Vademécum Perú 2026 has an age rating of 17+, suggesting it is intended for adult users due to the nature of the medical information it contains.
PR Vademécum Perú 2026 is a paid application, with a price of $19.99.
No, PR Vademécum Perú 2026 does not contain advertisements. It is a paid application designed to provide an uninterrupted user experience.
No, PR Vademécum Perú 2026 is intended as a supplementary tool for healthcare professionals. It should not be used as a sole means for prescribing medications, and users should rely on their professional judgment.
